These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients. Baco E; Ukimura O; Rud E; Vlatkovic L; Svindland A; Aron M; Palmer S; Matsugasumi T; Marien A; Bernhard JC; Rewcastle JC; Eggesbø HB; Gill IS Eur Urol; 2015 Apr; 67(4):787-94. PubMed ID: 25240973 [TBL] [Abstract][Full Text] [Related]
3. Cribriform morphology predicts upstaging after radical prostatectomy in patients with Gleason score 3 + 4 = 7 prostate cancer at transrectal ultrasound (TRUS)-guided needle biopsy. Keefe DT; Schieda N; El Hallani S; Breau RH; Morash C; Robertson SJ; Mai KT; Belanger EC; Flood TA Virchows Arch; 2015 Oct; 467(4):437-42. PubMed ID: 26229020 [TBL] [Abstract][Full Text] [Related]
4. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen. Radtke JP; Schwab C; Wolf MB; Freitag MT; Alt CD; Kesch C; Popeneciu IV; Huettenbrink C; Gasch C; Klein T; Bonekamp D; Duensing S; Roth W; Schueler S; Stock C; Schlemmer HP; Roethke M; Hohenfellner M; Hadaschik BA Eur Urol; 2016 Nov; 70(5):846-853. PubMed ID: 26810346 [TBL] [Abstract][Full Text] [Related]
5. The use of targeted MR-guided prostate biopsy reduces the risk of Gleason upgrading on radical prostatectomy. Arsov C; Becker N; Rabenalt R; Hiester A; Quentin M; Dietzel F; Antoch G; Gabbert HE; Albers P; Schimmöller L J Cancer Res Clin Oncol; 2015 Nov; 141(11):2061-8. PubMed ID: 26013424 [TBL] [Abstract][Full Text] [Related]
6. Multiparametric MRI in detection and staging of prostate cancer. Boesen L Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066 [TBL] [Abstract][Full Text] [Related]
7. Pathological Concordance between Prostate Biopsies and Radical Prostatectomy Using Transperineal Sector Mapping Biopsies: Validation and Comparison with Transrectal Biopsies. Marra G; Eldred-Evans D; Challacombe B; Van Hemelrijck M; Polson A; Pomplun S; Foster CS; Brown C; Cahill D; Gontero P; Popert R; Muir G Urol Int; 2017; 99(2):168-176. PubMed ID: 28768264 [TBL] [Abstract][Full Text] [Related]
8. Localising prostate cancer: comparison of endorectal magnetic resonance (MR) imaging and 3D-MR spectroscopic imaging with transrectal ultrasound-guided biopsy. Goris Gbenou MC; Peltier A; Addla SK; Lemort M; Bollens R; Larsimont D; Roumeguère T; Schulman CC; van Velthoven R Urol Int; 2012; 88(1):12-7. PubMed ID: 22004874 [TBL] [Abstract][Full Text] [Related]
9. High concordance of findings obtained from transgluteal magnetic resonance imaging - and transrectal ultrasonography-guided biopsy as compared with prostatectomy specimens. Steurer S; Rico SD; Simon R; Minner S; Tsourlakis MC; Krech T; Koop C; Graefen M; Heinzer H; Adam M; Huland H; Schlomm T; Sauter G; Lumiani A BJU Int; 2017 Sep; 120(3):365-376. PubMed ID: 28295933 [TBL] [Abstract][Full Text] [Related]
10. Combined T2 and diffusion-weighted MR imaging with template prostate biopsies in men suspected with prostate cancer but negative transrectal ultrasound-guided biopsies. Sheikh N; Wei C; Szewczyk-Bieda M; Campbell A; Memon S; Lang S; Nabi G World J Urol; 2017 Feb; 35(2):213-220. PubMed ID: 27236302 [TBL] [Abstract][Full Text] [Related]
11. Comparison of free-hand transperineal mpMRI/TRUS fusion-guided biopsy with transperineal 12-core systematic biopsy for the diagnosis of prostate cancer: a single-center prospective study in China. Zhang Q; Wang W; Zhang B; Shi J; Fu Y; Li D; Guo S; Zhang S; Huang H; Jiang X; Zhou W; Guo H Int Urol Nephrol; 2017 Mar; 49(3):439-448. PubMed ID: 28005230 [TBL] [Abstract][Full Text] [Related]
12. Multiparametric MRI in men with clinical suspicion of prostate cancer undergoing repeat biopsy: a prospective comparison with clinical findings and histopathology. Boesen L; Nørgaard N; Løgager V; Balslev I; Thomsen HS Acta Radiol; 2018 Mar; 59(3):371-380. PubMed ID: 28679325 [TBL] [Abstract][Full Text] [Related]
13. Direct comparison of multiparametric magnetic resonance imaging (MRI) results with final histopathology in patients with proven prostate cancer in MRI/ultrasonography-fusion biopsy. Borkowetz A; Platzek I; Toma M; Renner T; Herout R; Baunacke M; Laniado M; Baretton G; Froehner M; Zastrow S; Wirth M BJU Int; 2016 Aug; 118(2):213-20. PubMed ID: 26935133 [TBL] [Abstract][Full Text] [Related]
14. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer. Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676 [TBL] [Abstract][Full Text] [Related]
15. Utility of Gleason pattern 4 morphologies detected on transrectal ultrasound (TRUS)-guided biopsies for prediction of upgrading or upstaging in Gleason score 3 + 4 = 7 prostate cancer. Flood TA; Schieda N; Keefe DT; Breau RH; Morash C; Hogan K; Belanger EC; Mai KT; Robertson SJ Virchows Arch; 2016 Sep; 469(3):313-9. PubMed ID: 27394432 [TBL] [Abstract][Full Text] [Related]
16. New prostate cancer prognostic grade group (PGG): Can multiparametric MRI (mpMRI) accurately separate patients with low-, intermediate-, and high-grade cancer? Holtz JN; Silverman RK; Tay KJ; Browning JT; Huang J; Polascik TJ; Gupta RT Abdom Radiol (NY); 2018 Mar; 43(3):702-712. PubMed ID: 28721479 [TBL] [Abstract][Full Text] [Related]
17. An initial negative round of targeted biopsies in men with highly suspicious multiparametric magnetic resonance findings does not exclude clinically significant prostate cancer-Preliminary experience. Costa DN; Kay FU; Pedrosa I; Kolski L; Lotan Y; Roehrborn CG; Hornberger B; Xi Y; Francis F; Rofsky NM Urol Oncol; 2017 Apr; 35(4):149.e15-149.e21. PubMed ID: 27939349 [TBL] [Abstract][Full Text] [Related]
18. Comparison of Transrectal Ultrasound Biopsy to Transperineal Template Mapping Biopsies Stratified by Multiparametric Magnetic Resonance Imaging Score in the PROMIS Trial. Lovegrove CE; Miah S; El-Shater Bosaily A; Bott S; Brown L; Burns-Cox N; Dudderidge T; Freeman A; Henderson A; Hindley R; Kaplan R; Kirkham A; Oldroyd R; Parker C; Persad R; Punwani S; Rosario D; Shergill I; Winkler M; Emberton M; Ahmed HU J Urol; 2020 Jan; 203(1):100-107. PubMed ID: 31335254 [TBL] [Abstract][Full Text] [Related]
19. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies. Pokorny MR; de Rooij M; Duncan E; Schröder FH; Parkinson R; Barentsz JO; Thompson LC Eur Urol; 2014 Jul; 66(1):22-9. PubMed ID: 24666839 [TBL] [Abstract][Full Text] [Related]
20. [Real-time MRI/US fusion-guided biopsy improves detection rates of prostate cancer in pre-biopsied patients]. Maxeiner A; Fischer T; Stephan C; Cash H; Slowinski T; Kilic E; Durmus T Aktuelle Urol; 2014 May; 45(3):197-203. PubMed ID: 24902069 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]